University of Pittsburgh Medical Center
Pittsburgh, Pennsylvania, 15213, United States
NCT Number: NCT04480671
This is a randomized controlled surgical trial evaluating the use of a concomitant posterior colporrhaphy and/or perineorrhaphy at the conclusion of minimally invasive sacrocolpopexy to narrow enlarged genital hiatuses in a population of women with pelvic organ prolapse. The study's primary outcome is the proportion of women at 6 months postoperatively who still have an enlarged genital hiatus.
An exploratory sub-aim (as of October 2021) of the study is to evaluate the levator hiatal area as compared with the genital hiatus by using preoperative and postoperative transperineal ultrasounds. Subjects will be invited to participate, but is not required for study participation.
Looking for future studies?
Notify Me18 year and older
Female
Interventional
Not applicable
Pittsburgh, Pennsylvania, 15213, United States
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
subjects who are unable to complete questionnaires or repeat office exams or if they do not otherwise meet inclusion criteria above
*Note: we will NOT exclude patients based on prior surgical history (including prior posterior colporrhaphy)*
A level III support procedure is aimed at repairing the distal support of the vagina with either a posterior colporrhaphy and/or a perineorrhaphy.
All study participants are planning with their surgeon a minimally invasive sacrocolpopexy (robotic or laparoscopic) to repair pelvic organ prolapse.
Subjects from either arm will be invited to participate in this exploratory arm of the study. If they choose to participate, they will have a preoperative ultrasound performed and an ultrasound performed at the time of their 6 month visit.
Time frame: 6 months postoperatively
Proportion of subjects with enlarged genital hiatus on pelvic exam
Time frame: 12 months
Any anatomic prolapse recurrence beyond the hymen, symptomatic on questionnaire, or retreatment for prolapse with surgery or pessary.
Time frame: 24 months
Any symptomatic recurrence of prolapse on questionnaire
Time frame: 6, 12 months postoperatively
Incidence of pain with sex (dyspareunia), ascertained with the use of a validated questionnaire for sexual function [the Pelvic Organ Prolapse/Urinary Incontinence Sexual Questionnaire, IUGA-Revised (PISQ-IR)].This questionnaire indicates worse pain with sex with higher score.
Time frame: 6, 12 months postoperatively
Assessment of sexual function, ascertained with the use of a validated questionnaire for sexual function [the Pelvic Organ Prolapse/Urinary Incontinence Sexual Questionnaire, IUGA-Revised (PISQ-IR)]. This questionnaire helps us determine what impact pelvic organ prolapse has on sexual activity.
Time frame: baseline, 6, 12 months postoperatively
Measurement of pelvic floor distress change, using the Pelvic Floor Distress Inventory questionnaire (PFDI-20) which is a validated questionnaire used for pelvic floor disorders and their impact on patient quality of life.
Time frame: baseline, 6 months postoperatively
Measurement of the levator hiatus on transperineal ultrasound
University of Pittsburgh
Other
Impact of Level III Support Procedure on Normalization of Enlarged Genital Hiatus After Minimally Invasive Sacrocolpopexy: a Randomized Controlled Trial
Acronym: MERIT
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT02890498
Pathological Conditions, Anatomical, Pathological Conditions, Signs and Symptoms
Nîmes, France
View Trial DetailsNCT06532292
Pathological Conditions, Anatomical, Pathological Conditions, Signs and Symptoms
Taipei, Taiwan
View Trial DetailsNCT07554651
Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications
Dnipro, Ukraine
View Trial DetailsNCT07552337
Pathological Conditions, Anatomical, Pathological Conditions, Signs and Symptoms
Diyarbakır, Turkey (Türkiye)
View Trial Details